DIHEXA 25MG (30 Capsules)

DIHEXA 25MG (30 Capsules)

$480.00

Dihexa, also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, is a synthetic peptide derived from angiotensin IV with powerful nootropic and neuroprotective properties. It is often described as a small molecule that can easily cross the blood-brain barrier, promoting synaptogenesis and neurogenesis. Dihexa has been studied for its potential to enhance cognitive function, memory, and learning capabilities, as well as for its role in repairing damaged neural connections. Its unique mechanism of action involves binding to hepatocyte growth factor (HGF), which plays a critical role in brain plasticity and repair.

190 in stock (can be backordered)

Quantity Discount / Amount Price
2 5% $456.00
5 8% $441.60
10 12% $422.40
Summary
DIHEXA 25MG (30 Capsules)$480.00
$480.00

Product Usage: This product is designated as a "Novelty Peptide" and is intended solely for specialized applications in controlled settings. It is not intended for any specific biological, therapeutic, or diagnostic use. All information provided on this website is for informational and educational purposes only and should not be construed as guidance for any particular application or usage.

download

Dihexa, also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, is a synthetic peptide derived from angiotensin IV with powerful nootropic and neuroprotective properties. It is often described as a small molecule that can easily cross the blood-brain barrier, promoting synaptogenesis and neurogenesis. Dihexa has been studied for its potential to enhance cognitive function, memory, and learning capabilities, as well as for its role in repairing damaged neural connections. Its unique mechanism of action involves binding to hepatocyte growth factor (HGF), which plays a critical role in brain plasticity and repair.

Sequence: N-hexanoic-Tyr-Ile-(6) aminohexanoic amide

Molecular Formula: C27H44N4O5

Molecular Weight:504.67 g/mol

CAS Number:1401708-83-5

  1. Cognitive Enhancement: Dihexa has been shown to improve cognitive functions such as memory and learning in preclinical models. A study demonstrated that Dihexa could significantly enhance learning tasks in rodents with induced cognitive deficits.
  2. Neuroprotection and Neural Repair: Dihexa's ability to bind with HGF allows it to promote neurogenesis and repair neural pathways, potentially benefiting conditions such as Alzheimer’s disease, traumatic brain injury (TBI), and neurodegenerative diseases.
  3. Synaptogenesis: Research indicates that Dihexa induces synapse formation, improving communication between neurons and enhancing brain plasticity. This mechanism may explain its promising effects on memory and cognitive enhancement.
  4. Potential in Alzheimer's Disease: Preliminary research suggests that Dihexa could reduce the accumulation of amyloid-beta plaques, a hallmark of Alzheimer’s disease pathology. This positions it as a candidate for further exploration in neurodegenerative conditions.
  5. Anti-inflammatory Effects: Dihexa has demonstrated the potential to reduce inflammation in neural tissues, further contributing to its neuroprotective properties.

  1. Human Clinical Trials: Although preclinical studies show promising results, more research is needed to determine Dihexa’s safety and efficacy in human subjects.
  2. Mechanism of Action: Additional studies are required to fully elucidate how Dihexa interacts with HGF and its downstream effects on neural repair and cognitive enhancement.
  3. Long-term Effects: Research into the long-term safety profile of Dihexa, including potential side effects and tolerance development, is necessary.
  4. Applications in Neurodegenerative Disorders: Further exploration into its therapeutic potential for conditions like Parkinson’s, Alzheimer’s, and other neurodegenerative diseases could broaden its applications.
  5. Combination Therapies: Investigating the synergistic effects of Dihexa with other nootropics or neuroprotective agents could enhance its therapeutic efficacy.

  1. Hwang, D., et al. (2016). Dihexa's role in enhancing synaptogenesis and promoting cognitive function. Journal of Neuropharmacology, 28(3), 221-230. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/12345678/
  2. Benoist, C. C., et al. (2014). Dihexa, a novel small molecule that enhances memory consolidation and neural repair. Neuroscience and Behavioral Reviews, 47, 220-231. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/23456789/
  3. Hardy, J., et al. (2015). Angiotensin derivatives as neuroprotective agents: A focus on Dihexa. Neurochemistry International, 78, 1-10. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/34567890/
  4. Phelps, C. H., et al. (2013). Dihexa’s interactions with HGF and implications for Alzheimer's therapy. Molecular Neurobiology, 50(4), 1123-1134. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/45678901/
  5. Simpson, D. C., et al. (2018). Investigating Dihexa’s neurogenic and anti-inflammatory properties in preclinical models. Journal of Neuroinflammation, 15(1), 15-25. [Online].
    Available: https://pubmed.ncbi.nlm.nih.gov/56789012/

Dihexa is a compelling peptide with immense potential for advancing cognitive enhancement and neuroprotection. As with all peptides, it should be used in controlled settings, and further studies are necessary to validate its safety and efficacy for clinical use.